The seven-figure DTC ad campaign is an unusual tactic for the generics industry, which typically uses other channels for its advocacy.
The US generics trade group is appealing directly to patients in a campaign pushing for Medicare and other changes that it believes will lower drug prices.
Direct-to-consumer ads are rare, if ever used, by generics companies to push their medicines, unlike their brand counterparts, but now the Association for Accessible Medicines decided to roll out a...
President Trump’s new Executive Order on drug pricing reprises several policy themes from his first administration, including giving the FDA many tasks intended to increase competition in the marketplace.
Germany’s federal health care decision-making body, the G-BA, tells the Pink Sheet that German drug prices are fair and speculation of price rises in the market due to the US MFN policy is fear mongering.
In this first in a series of articles looking at the potential impact of the MFN drug pricing policy on European pharmaceutical markets, EUCOPE’s Alexander Natz tells the Pink Sheet why the US policy underscores the importance of confidential net pricing.
The FDA is not currently signaling that stringent rules for the process will be relaxed, but the agency's change in approach is notable.
In this first in a series of articles looking at the potential impact of the MFN drug pricing policy on European pharmaceutical markets, EUCOPE’s Alexander Natz tells the Pink Sheet why the US policy underscores the importance of confidential net pricing.
The FDA is not currently signaling that stringent rules for the process will be relaxed, but the agency's change in approach is notable.
Now that the landmark Pandemic Agreement has finally been adopted, work will start on drafting a pathogen access and benefit sharing system that will be voluntary for use by drug companies.
